MeCP2 repression of G9a in regulation of pain and morphine reward

Journal of Neuroscience

Volumn 34, Issue 27, 2014, Pages 9076-9087

  Zhang, Zhi ^a,b   Tao, Wenjuan ^b   Hou, Yuan Yuan ^a   Wang, Wei ^a   Kenny, Paul J ^c   Pan, Zhizhong Z ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

G9a; MeCP2; Opioid; Pain; Reward

Indexed keywords

7 [3 (DIMETHYLAMINO) PROPOXY] 2 (HEXAHYDRO 4 METHYL 1H 1, 4 DIAZEPIN 1 YL) 6 METHOXY N (1 METHYL 4 PIPERIDINYL) 4 QUINAZOLINAMINE; BRAIN DERIVED NEUROTROPHIC FACTOR; HISTONE DIMETHYLTRANSFERASE G9A; METHYL CPG BINDING PROTEIN 2; MORPHINE; N (1 BENZYL 4 PIPERIDINYL) 2 (HEXAHYDRO 4 METHYL 1H 1, 4 DIAZEPIN 1 YL) 6, 7 DIMETHOXY 4 QUINAZOLINAMINE; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME REPRESSION; EPIGENETICS; FEMALE; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; PAIN; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REWARD BEHAVIOR; WESTERN BLOTTING;

G9A; MECP2; OPIOID; PAIN; REWARD;

AMYGDALA; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHRONIC PAIN; CONDITIONING, CLASSICAL; CROSSES, GENETIC; DISEASE SUSCEPTIBILITY; DOWN-REGULATION; EMOTIONS; EPIGENESIS, GENETIC; EXPLORATORY BEHAVIOR; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GENETIC VECTORS; HISTONE-LYSINE N-METHYLTRANSFERASE; MALE; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, INBRED C57BL; MORPHINE; MORPHINE DEPENDENCE; NARCOTICS; NERVE TISSUE PROTEINS; RECOMBINANT FUSION PROTEINS; REINFORCEMENT (PSYCHOLOGY); REWARD; TRANSGENES;

EID: 84903640290     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4194-13.2014     Document Type: Article

References (56)

1. Ballantyne J. C, LaForge KS (2007) Opioid dependence and addiction during opioid treatment of chronic pain. Pain 129:235-255. CrossRef Medline
2. Basbaum A. I, Bautista DM, Scherrer G, Julius D (2009) Cellular and molecular mechanisms of pain. Cell 139:267-284. CrossRef Medline
3. Baxter M. G, Murray EA (2002) The amygdala and reward. Nat Rev Neurosci 3:563-573. CrossRef Medline
4. Becerra L., Breiter HC, Wise R, Gonzalez RG, Borsook D (2001) Reward circuitry activation by noxious thermal stimuli. Neuron 32:927-946. CrossRef Medline
5. Bie B., Zhu W, Pan ZZ (2009) Ethanol-induced delta-opioid receptor modulation of glutamate synaptic transmission and conditioned place preference in central amygdala. Neuroscience 160:348-358. CrossRef Medline
6. Bienvenu T., Chelly J (2006) Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized. Nat Rev Genet 7:415-426. CrossRef Medline
7. Cahill C. M, Xue L, Grenier P, Magnussen C, Lecour S, Olmstead MC (2013) Changes in morphine reward in a model of neuropathic pain. Behav Pharmacol 24:207-213. CrossRef Medline
8. Cai Y. Q, Wang W, Hou YY, Zhang Z, Xie J, Pan ZZ (2013) Central amygdala GluA1 facilitates associative learning of opioid reward. J Neurosci 33: 1577-1588. CrossRef Medline
9. Chahrour M., Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320:1224-1229. CrossRef Medline
10. Chang Q., Khare G, Dani V, Nelson S, Jaenisch R (2006) The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 49:341-348. CrossRef Medline
11. Chen W. G, Chang Q, Lin Y, Meissner A, West AE, Griffith EC, Jaenisch R, Greenberg M. E (2003) Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302:885-889. CrossRef Medline
12. Colpaert F. C, Tarayre JP, Alliaga M, Bruins Slot LA, Attal N, KoekW (2001) Opiate self-administration as a measure of chronic nociceptive pain in arthritic rats. Pain 91:33-45. CrossRef Medline
13. Deng J. V, Rodriguiz RM, Hutchinson AN, Kim IH, Wetsel WC, West AE (2010) MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants. Nat Neurosci 13:1128-1136. CrossRef Medline
14. Denk F., McMahon SB (2012) Chronic pain: emerging evidence for the involvement of epigenetics. Neuron 73:435-444. CrossRef Medline
15. Ebert D. H, Gabel HW, Robinson ND, Kastan NR, Hu LS, Cohen S, Navarro AJ, Lyst MJ, Ekiert R, Bird AP, Greenberg ME (2013) Activitydependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoR. Nature 499:341-345. CrossRef Medline
16. Edlund M. J, Steffick D, Hudson T, Harris KM, Sullivan M (2007) Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain 129:355-362. CrossRef Medline
17. Fields H. (2004) State-dependent opioid control of pain. Nat Rev Neurosci 5:565-575. CrossRef Medline
18. Géranton S. M, Morenilla-Palao C, Hunt SP (2007) A role for transcriptional repressor methyl-CpG-binding protein 2 and plasticity-related gene serum-and glucocorticoid-inducible kinase 1 in the induction of inflammatory pain states. J Neurosci 27:6163-6173. CrossRef Medline
19. Gottfried J. A, O'Doherty J, Dolan RJ (2003) Encoding predictive reward value in human amygdala and orbitofrontal cortex. Science 301:1104-1107. CrossRef Medline
20. Guy J., Cheval H, Selfridge J, Bird A (2011) The role of MeCP2 in the brain. Annu Rev Cell Dev Biol 27:631-652. CrossRef Medline
21. Hyman S. E, Malenka RC, Nestler EJ (2006) Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29:565-598. CrossRef Medline
22. Im H. I, Hollander JA, Bali P, Kenny PJ (2010) MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat Neurosci 13:1120-1127. CrossRef Medline
23. King T., Vera-Portocarrero L, Gutierrez T, Vanderah TW, Dussor G, Lai J, Fields H. L, Porreca F (2009) Unmasking the tonic-aversive state in neuropathic pain. Nat Neurosci 12:1364-1366. CrossRef Medline
24. Koob G. F, Ahmed SH, Boutrel B, Chen SA, Kenny PJ, Markou A, O'Dell LE, Parsons L. H, Sanna PP (2004) Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev 27:739-749. CrossRef Medline
25. Kupers R., Gybels J (1995) The consumption of fentanyl is increased in rats with nociceptive but not with neuropathic pain. Pain 60:137-141. CrossRef Medline
26. Kynast K. L, Russe OQ, Möser CV, Geisslinger G, Niederberger E (2013) Modulation of central nervous system-specific microRNA-124a alters the inflammatory response in the formalin test in mice. Pain 154:368-376. CrossRef Medline
27. Lewis J. D, Meehan RR, Henzel WJ, Maurer-Fogy I, Jeppesen P, Klein F, Bird A (1992) Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69:905-914. CrossRef Medline
28. Li B., Carey M, Workman JL (2007) The role of chromatin during transcription. Cell 128:707-719. CrossRef Medline
29. Martin T. J, Ewan E (2008) Chronic pain alters drug self-administration: implications for addiction and pain mechanisms. Exp Clin Psychopharmacol 16:357-366. CrossRef Medline
30. Martinowich K., Hattori D, WuH, Fouse S, He F, HuY, Fan G, Sun YE (2003) DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302:890-893. CrossRef Medline
31. Maze I., Covington HE 3rd, Dietz DM, LaPlant Q, Renthal W, Russo SJ, Mechanic M., Mouzon E, Neve RL, Haggarty SJ, Ren Y, Sampath SC, Hurd YL, Greengard P, Tarakhovsky A, Schaefer A, Nestler EJ (2010) Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science 327:213-216. CrossRef Medline
32. Narita M., Kishimoto Y, Ise Y, Yajima Y, Misawa K, Suzuki T (2005) Direct evidence for the involvement of the mesolimbic kappa-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state. Neuropsychopharmacology 30:111-118. CrossRef Medline
33. Neugebauer V., Galhardo V, Maione S, Mackey SC (2009) Forebrain pain mechanisms. Brain Res Rev 60:226-242. CrossRef Medline
34. Ooi L., Wood IC (2007) Chromatin crosstalk in development and disease: lessons from REST. Nat Rev Genet 8:544-554. CrossRef Medline
35. Ozaki S., Narita M, Narita M, Iino M, Miyoshi K, Suzuki T (2003) Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: involvement of G-protein-coupled receptor kinase 2. Neuroscience 116:89-97. CrossRef Medline
36. Pan Z. Z, Tershner SA, Fields HL (1997) Cellular mechanism for antianalgesic action of agonists of the kappa-opioid receptor. Nature 389: 382-385. CrossRef Medline
37. Passik S. D, Kirsh KL (2011) Addictions in pain clinics and pain treatment. Ann N. Y Acad Sci 1216:138-143. CrossRef Medline
38. Pezet S., McMahon SB (2006) Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci 29:507-538. CrossRef Medline
39. Pickens C. L, Airavaara M, Theberge F, Fanous S, Hope BT, Shaham Y (2011) Neurobiology of the incubation of drug craving. Trends Neurosci 34:411-420. CrossRef Medline
40. Pitkänen A., Savander V, LeDoux JE (1997) Organization of intraamygdaloid circuitries in the rat: an emerging framework for understanding functions of the amygdala. Trends Neurosci 20:517-523. CrossRef Medline
41. Rathert P., Dhayalan A, Murakami M, Zhang X, Tamas R, Jurkowska R, Komatsu Y, Shinkai Y, Cheng X, Jeltsch A (2008) Protein lysine methyltransferase G9a acts on non-histone targets. Nat Chem Biol 4:344-346. CrossRef Medline
42. Robison A. J, Nestler EJ (2011) Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 12:623-637. CrossRef Medline
43. Sadri-Vakili G., Kumaresan V, Schmidt HD, Famous KR, Chawla P, Vassoler FM, Overland RP, Xia E, Bass CE, Terwilliger EF, Pierce RC, Cha JH (2010) Cocaine-induced chromatin remodeling increases brain-derived neurotrophic factor transcription in the rat medial prefrontal cortex, which alters the reinforcing efficacy of cocaine. J Neurosci 30:11735-11744. CrossRef Medline
44. Samaco R. C, Neul JL (2011) Complexities of Rett syndrome and MeCP2. J Neurosci 31:7951-7959. CrossRef Medline
45. See R. E, Fuchs RA, Ledford CC, McLaughlin J (2003) Drug addiction, relapse, and the amygdala. Ann N Y Acad Sci 985:294-307. Medline
46. Shankar S. R, Bahirvani AG, Rao VK, Bharathy N, Ow JR, Taneja R (2013) G9a, a multipotent regulator of gene expression. Epigenetics 8:16-22. CrossRef Medline
47. Sufka K. J (1994) Conditioned place preference paradigm: a novel approach for analgesic drug assessment against chronic pain. Pain 58:355-366. CrossRef Medline
48. Sun H., Maze I, Dietz DM, Scobie KN, Kennedy PJ, Damez-Werno D, Neve RL, Zachariou V, Shen L, Nestler EJ (2012) Morphine epigenomically regulates behavior through alterations in histone H3 lysine 9 dimethylation in the nucleus accumbens. J Neurosci 32:17454-17464. CrossRef Medline
49. Sun Y. E, Wu H (2006) The ups and downs of BDNF in Rett syndrome. Neuron 49:321-323. CrossRef Medline
50. Tochiki K. K, Cunningham J, Hunt SP, Géranton SM (2012) The expression of spinal methyl-CpG-binding protein 2, DNA methyltransferases and histone deacetylases is modulated in persistent pain states. Mol Pain 8:14. CrossRef Medline
51. Tzschentke T. M (2007) Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 12:227-462. CrossRef Medline
52. Urban R., Scherrer G, Goulding EH, Tecott LH, Basbaum AI (2011) Behavioral indices of ongoing pain are largely unchanged in male mice with tissue or nerve injury-induced mechanical hypersensitivity. Pain 152: 990-1000. CrossRef Medline
53. Woolf C. J, Hashmi M (2004) Use and abuse of opioid analgesics: potential methods to prevent and deter non-medical consumption of prescription opioids. Curr Opin Investig Drugs 5:61-66. Medline
54. Yasui D. H, Peddada S, Bieda MC, Vallero RO, Hogart A, Nagarajan RP, Thatcher K. N, Farnham PJ, Lasalle JM (2007) Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci U S A 104:19416-19421. CrossRef Medline
55. Zhang Z., Cai YQ, Zou F, Bie B, Pan ZZ (2011) Epigenetic suppression of GAD65 expression mediates persistent pain. Nat Med 17:1448-1455. CrossRef Medline
56. Zubieta J. K, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, Meyer CR, Koeppe R. A, Stohler CS (2001) Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 293:311-315. CrossRef Medline